| Belgium exports to Canada · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Czechia · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Denmark · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Finland · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to France · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Germany · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Greece · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Guatemala · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Australia · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Indonesia · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Ireland · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Israel · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Italy · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Japan · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Austria · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Jordan · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Rep. of Korea · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Luxembourg · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Mexico · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Morocco · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Netherlands · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Nigeria · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Norway · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Philippines · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Poland · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Portugal · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to India · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Slovenia · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Spain · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Sweden · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Switzerland · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Brazil · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Tunisia · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Türkiye · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Egypt · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to United Kingdom · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to USA · Antibiotics: n.e.s. in heading no. 2941 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Canada · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Denmark · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to France · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Germany · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Greece · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Israel · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Italy · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Japan · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Luxembourg · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Netherlands · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Portugal · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Saudi Arabia · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to India · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Spain · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Sweden · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Switzerland · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to United Kingdom · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to USA · Organic compounds: n.e.s. in chapter 29 | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to France · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Germany · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Italy · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Luxembourg · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Netherlands · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Switzerland · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Canada · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Denmark · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to France · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Germany · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Italy · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Japan · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Austria · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Luxembourg · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Netherlands · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Sweden · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Switzerland · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to United Kingdom · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to USA · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Bulgaria · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Canada · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Croatia · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Cyprus · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Czechia · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Denmark · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Estonia · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Finland · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to France · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Germany · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Greece · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Argentina · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to China, Hong Kong SAR · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Hungary · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Australia · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Ireland · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Israel · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Italy · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Japan · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Austria · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Rep. of Korea · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Lithuania · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Luxembourg · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Mexico · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Netherlands · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
| Belgium exports to Norway · Blood: human and animal, antisera and other blood fractions | Belgium | USD | Annual | 2024-01-01 | CEPII |
Research Data